More positive results from Argex's West Hervieux target drilling

    
    - 351 feet (107.0 metres) of 0.52% V2O5, 64.33% Fe2O3 and
      19.48% TiO2 in holes HW-10-031
    - 346 feet (105.4 metres) of 0.50% V2O5, 61.92% Fe2O3 and
      17.85% TiO2 in hole HW-10-029
    - Results for 9 additional holes complete, 8 holes pending results
    - Nearly 15,000 m of drilling completed on the La Blache property since
      the start of 2010 drilling
    

MONTREAL, June 8 /CNW Telbec/ - Argex Silver Capital Inc. TSX-V:RGX Argex or the Company reports additional final results intersected from drilling at the La Blache property, West Hervieux occurrence. Many of the intersections include internal dilution of mineralization by unmineralized dykes. Based on these results and the holes that are pending at the lab, Argex plans to return to drilling at the West Hervieux target.

Assay results continue to confirm visual identification of well mineralized massive titaniferous magnetite. Wide intersections of 105.4m (346 feet) of 61.92 % Fe2O3, 17.85% TiO2 and 0.50% V2O5 in hole HW-10-029, and 107m (351 feet) of 64.33 % Fe2O3, 19.48% TiO2 and 0.52% V2O5 in hole HW-10-031.In hole HW-10-030, three separate zones of massive titaniferous magnetite were intersected for a total of 147.55 m (484 feet) of mineralization.

Drilling on the La Blache Properties has now seen in excess of 110 holes totaling more than 6000 metres completed in 41 holes at the West Hervieux occurrence and nearly 9000m in 69 holes on the East Hervieux occurrence, located approximately 2 km east and 1.25 km north of the West Hervieux Occurrence.

All results are drill intersections along the length of the core and may not be representative of the true thickness. See the intersection and preliminary results table below (all results are fina1):

    
    -------------------------------------------------------------------------

                       Length
                        along
    HOLE                 core                          Fe2O3    TiO2   V2O5
    No.          From      (m)   Fe(%)   Ti(%)   V(%)     (%)     (%)    (%)
    -------------------------------------------------------------------------
    HW-10-025                          assays pending
    -------------------------------------------------------------------------
    HW-10-026                          assays pending
    -------------------------------------------------------------------------
    HW-10-027                          assays pending
    -------------------------------------------------------------------------
    HW-10-028                          assays pending
    -------------------------------------------------------------------------
    HW-10-029     4.6   105.4   43.31   10.70   0.28   61.92   17.85   0.50
    ---------------------------
    HW-10-029   119.7     1.2   43.45   11.14   0.30   62.12   18.58   0.53
    ---------------------------
    HW-10-029   128.3     0.3   35.30    8.43   0.23   50.47   14.06   0.41
    ---------------------------
    HW-10-029   133.5   13.05   43.21   11.47   0.29   61.77   19.13   0.52
    ---------------------------
    HW-10-029   150.6     2.6   43.48   12.64   0.29   62.17   21.08   0.51
    -------------------------------------------------------------------------
    HW-10-030     3.8   36.85   44.21   11.02   0.27   63.20   18.39   0.48
    ---------------------------
    HW-10-030    50.9    51.9   43.05   11.13   0.28   61.55   18.57   0.50
    ---------------------------
    HW-10-030   108.5    58.8   37.07    9.29   0.26   53.00   15.50   0.46
    -------------------------------------------------------------------------
    HW-10-031       4     107   44.99   11.68   0.29   64.33   19.48   0.52
    ---------------------------
    HW-10-031     117       5   42.78   11.14   0.28   61.16   18.58   0.50
    ---------------------------
    HW-10-031     130     7.4   42.43   10.92   0.29   60.66   18.21   0.52
    ---------------------------
    HW-10-031     144     0.5   45.20   10.85   0.21   64.62   18.10   0.37
    -------------------------------------------------------------------------
    HW-10-032                          assays pending
    -------------------------------------------------------------------------
    HW-10-033                          assays pending
    -------------------------------------------------------------------------
    HW-10-034                          assays pending
    -------------------------------------------------------------------------
    HW-10-035       7     0.9   40.50   12.35   0.30   57.90   20.60   0.54
    ---------------------------
    HW-10-035    11.9     6.1   32.95    8.80   0.21   47.10   14.68   0.37
    ---------------------------
    HW-10-035    29.8     1.2   39.90   10.45   0.27   57.05   17.43   0.48
    ---------------------------
    HW-10-035    40.3     0.9   41.16   10.85   0.27   58.85   18.09   0.47
    ---------------------------
    HW-10-035   41.55    2.05   41.56   10.83   0.27   59.42   18.07   0.48
    ---------------------------
    HW-10-035    46.8    11.7   42.67   10.80   0.29   61.00   18.02   0.52
    ---------------------------
    HW-10-035   64.85    8.15   43.86   10.97   0.28   62.71   18.29   0.50
    ---------------------------
    HW-10-035    79.3     1.2   44.39   11.97   0.31   63.47   19.97   0.55
    -------------------------------------------------------------------------
    HW-10-036                          assays pending
    -------------------------------------------------------------------------
    HW-10-037                               NSV
    -------------------------------------------------------------------------
    HW-10-038                               NSV
    -------------------------------------------------------------------------
    HW-10-039    53.5     5.2   25.58    6.79   0.16   36.57   11.32   0.29
    ---------------------------
    HW-10-039   127.1    67.1   41.76   10.83   0.27   59.70   18.07   0.48
    -------------------------------------------------------------------------
    HW-10-040                               NSV
    -------------------------------------------------------------------------
    HW-10-041                               NSV
    -------------------------------------------------------------------------
    NSV - No Significant Values
    

The drill program was planned and is being supervised by Jean-Sébastien Lavallée, P.Geo (OGQ #773), Consul-Teck Exploration Inc., of Val d'or, Québec, Argex's Silver Capital Inc. consulting geologist and qualified person since 2007, as well as reviewing and approving this release. The drilling is being completed Major Drilling Group International Inc, with crews being based out of the Val d'or, Québec office Samples were sent for analysis in sealed containers to the Chemex laboratory in Val-d'Or by employees of Consul-Teck Exploration Inc. Chemex is the laboratory used for analysis of all samples from programs on the La Blache property. The samples are weighed and identified prior to sample preparation. The samples are crushed to 70% minus 2 mm, then separation and pulverized to 85% passing 75 (micro)m. All samples are analyzed using ICP-81 (Iron-Titanium) and using ME-XRF-10 for Vanadium.

About Argex

Argex is a junior titanium, iron, vanadium and magnesium explorer with projects in Quebec, Canada. Headquartered in Montreal, Quebec, the Company is committed to the interests of its shareholders, with plans to rapidly advance towards titanium production at the 100% owned La Blache deposit located near Baie-Comeau, Quebec. For additional information please visit our website at www.argex.ca.

Forward-Looking Statements

This news release contains discussion of items that may constitute forward-looking statements within the meaning of securities laws that involve risks and uncertainties. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be achieved. Factors that could cause actual results to differ materially from expectations include the effects of general economic conditions, actions by government authorities, uncertainties associated with contract negotiations, additional financing requirements, market acceptance of the Company's products and competitive pressures. These factors and others are more fully discussed in Company filings with Canadian securities regulatory authorities

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Argex Titanium Inc.

For further information: For further information: Michael Dehn, President and CEO, Argex Silver Capital Inc, (647) 477-2382, michael@avantimac.com; Paradox Public relations, (514) 341-0408, 1-866-460-0408

Organization Profile

Argex Titanium Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890